Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug may cut blood transfusions for MDS patients in asia

NCT ID NCT04477850

Completed Disease control Sponsor: Celgene Source: ClinicalTrials.gov ↗

First seen May 11, 2026 · Last updated May 11, 2026

Summary

This study tested a drug called luspatercept in 30 Chinese and Japanese adults with a bone marrow condition (MDS) that causes severe anemia. Participants needed regular red blood cell transfusions. The goal was to see if the drug could help them go at least 8 weeks without a transfusion. The study also checked safety and how the drug works in the body.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Local Institution - 100

    Beijing, 100730, China

  • Local Institution - 101

    Shanghai, 200233, China

  • Local Institution - 102

    Hangzhou, 310006, China

  • Local Institution - 103

    Guangzhou, 510080, China

  • Local Institution - 104

    Suzhu, 215006, China

  • Local Institution - 105

    Guangzhou, 510060, China

  • Local Institution - 106

    Tianjin, 300020, China

  • Local Institution - 107

    Chengdu, Sichuan, 610041, China

  • Local Institution - 108

    Nanjing, 210029, China

  • Local Institution - 109

    Guangzhou, 510515, China

  • Local Institution - 110

    Wuhan, 430022, China

  • Local Institution - 111

    Wenzhou, 325000, China

  • Local Institution - 112

    Nanchang, 330006, China

  • Local Institution - 114

    Shanghai, 0, China

  • Local Institution - 201

    Mibu-Machi, 321-0293, Japan

  • Local Institution - 202

    Shinagawa-ku, Tokyo, 141-8625, Japan

  • Local Institution - 203

    Nagasaki, Nagasaki, 8528511, Japan

  • Local Institution - 204

    Sagamihara, 252-0375, Japan

  • Local Institution - 205

    Osaka, 545-8585, Japan

  • Local Institution - 206

    Kamogawa, 296-8602, Japan

  • Local Institution - 207

    Sendai, 980-8574, Japan

  • Local Institution - 208

    Ōgaki, 503-8502, Japan

  • Local Institution - 209

    Matsuyama, Ehime, 790-8524, Japan

  • Local Institution - 210

    Sayama, Osaka, 5898511, Japan

  • Local Institution - UNK11

    Fukuoka, 810-8563, Japan

Conditions

Explore the condition pages connected to this study.

MYELODYSPLASTIC SYNDROMES